Today’s AI Top Pick: TASK

7/31/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · TASK85%320 resolved forecasts · 45d window · verify →

Today's pick · Low Float Bullish Consensus Deep RotationTASKBUY NOW8.4 / 107/31/2026

TaskUs (TASK) is the cleanest intersection of screen thesis + tape confirmation + news tailwind in this pool. Fundamentally it's the best-of-breed low-float name: PE 5.21, fwdPe 3.84, ROE 26.52%, profit margin 8.7%, salesYoY +15.95%, and recom 2.86 with targetUpsidePct 48.9% — real profitability at a genuinely cheap multiple, not a busted biotech. Fundamental_score 5.75 is tied with AZO/IDN but TASK has actual growth and cash generation behind it. The multi-timeframe tape confirms without begging to chase. 1h fc_short is barely positive (+2.35%) with position_in_21bar_range only 11.54% and drawdown -10.47% — you're buying into weakness, not strength. Then 4h forecasts explode (+51.35 / +88.77 / +84.10) and 1d follows (+41.78 / +35.59 / +28.65), with 1wk still constructive (+1.91 / +16.03 / +21.97). Bullish_prob 1.0, near_term_bullish 0.6, and importantly the 1wk position is 43.49% (middle of range) with dd_from_21bar_high -20.49% — this is a coiled setup, not an extended one. Recent headlines are a net tailwind: TaskUs surged 5.1% on 7/28, Wedbush called top-client exit risk 'unlikely' on 7/24, and post-Q1 coverage is buy-lean. No dilution, no legal overhang, no short-seller report — the landmine check is clean (shortFloat 11.31% is elevated but manageable and can accelerate a squeeze). Why today vs. wait: 1h is at the low end of its range with a still-positive forward forecast, so you're not chasing the 4h/1d ramps that are already baked in. MORN scored higher on paper (13.32) but its 1h/4h forecasts are actually NEGATIVE (-9.75%, -7.59%) and it sits at 100% of the 1wk range — that's textbook chasing. AZO's 1wk forecast is negative (-6.5%). GPI has better fundamentals but flat 1wk tape (+0.74 / -0.03 / +1.28). TASK is the only name where fundamentals, multi-TF forecast alignment, entry location in range, and news all point the same direction.

Entry zone

5.75 - 5.95 (current 5.90, add on any dip toward 1h VWAP)

Stop loss

5.25 (below the -10.47% 1h drawdown low, ~11% risk)

First target

6.85 (approx +16%, aligns with 1d fc_short +41.78% scaled back and the 4h high recovery)

Longer target

8.75 - 9.00 (+48-52%, matches targetUpsidePct 48.9% and 4h fc_mid trajectory)

Risks

shortFloat 11.31% cuts both ways — squeeze fuel but also skeptics; a broken 5.25 stop likely cascades
recom 2.86 is the weakest analyst tone among top-tier candidates (MORN 1.67, AZO 1.42) — Street is not yet piling in
debtEq 1.99 is elevated; any client concentration hit (recall the top-client exit narrative Wedbush addressed) hurts fast
1wk recent_21bar_pct is -11.25% — the weekly trend is still repairing, so a failed bounce could retest -20% dd zone
PEG 1.99 means growth is priced closer to fair vs. the fwdPe headline; miss on next print would compress multiple

Honorable mentions

GPIBest fundamentals in the pool (fund_score 6.25, PE 11.35, PEG 0.79, fwdPe 6.47, ROE 11.05, instOwn 98.36%), 1d forecast +15.24/+25.31/+31.00, position only 11.96% in daily range with -17% drawdown = classic buy-the-dip on a quality name. Held back by flat 1wk forecast (+0.74/-0.03/+1.28) and just-released Q2 earnings creating headline risk in either direction.

MORNTop raw score (13.32), Q2 beat, fund_score 7.25 with ROE 31.96%, PEG 0.78 — best fundamentals overall. But 1h fc_short -9.75% and 4h fc_short -7.59% signal near-term exhaustion, and pos_in_21bar_range is 100% on 1wk. Great business, wrong entry point today — wait for pullback to 178-182.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	TASK	BUY NOW	8.4	Cheap profitable low-float with 4h/1d forecasts +40-88% and entry near 1h range low.
2	GPI	BUY NOW	7.6	Best fundamentals in pool at 11.96% of daily range with -17% drawdown — quality dip.
3	MORN	BUY PULLBACK	7.2	Elite fundamentals and Q2 beat, but at 100% of weekly range with negative 1h/4h forecasts — don't chase.
4	AZO	BUY PULLBACK	6.8	Quality retailer with 1d fc +8/+19/+22 but 1wk forecast turns negative — wait for firmer weekly.
5	LBRDA	BUY NOW	6.5	Multi-TF fully aligned (1h/4h/1d/1wk all positive), 1d forecast +21/+47/+68, near-term bullish 1.0.
6	IDN	BUY PULLBACK	5.8	Huge 1h forecast +107% but 1wk still bleeding (-21.7%, position 1.03%) and near-term bullish only 0.2.
7	TNXP	BUY PULLBACK	5.6	Medicare coverage catalyst and ~50k% weekly forecast is noise but 1d +11/+43/+70 with -25% dd is real.
8	GRCE	BUY PULLBACK	5.4	FDA Type A meeting minutes positive, forecasts +21/+65/+64 on 1d but at 0% range position with -60% weekly dd.
9	GLMD	WAIT	5.2	Aramchol Parkinson's/cardiac news constructive; 1d fc +7/+54/+100 but recom 1 with $5M cap = illiquid.
10	DRMA	WAIT	5.0	1h/4h/1d forecasts positive but 1wk forecast +10,927% is data noise — micro-cap $4.75M.
11	BCDA	BUY PULLBACK	4.9	Near-term bullish 1.0 and forecasts +20/+85/+77 on 1d, but salesYoY -100% and ROE -950%.
12	LTRN	BUY PULLBACK	4.8	EMA clearance + USPTO patent tailwinds, 4h -35% drawdown creates entry; 1d fc +11/+34/+27.
13	NXL	WAIT	4.6	Near-term bullish 0.8, 1d fc +21/+57/+92, but ROE -319% and $7.5M cap = high risk.
14	YCBD	WAIT	4.5	RSI 23.9 oversold with positive forecasts but 4h/1d dd -40% and profit margin -15.6%.
15	XTLB	WAIT	4.4	1wk fc +16/+80/+101 attractive but 4h fc_short -1.98% breaks alignment; ADR liquidity risk.
16	QNTM	AVOID	4.3	Big forecasts but ROE -984%, debtEq 1.45, -87% year — speculation, not investment.
17	INDP	WAIT	4.1	Near-term bullish 1.0 and 1wk fc +478%, but 4h/1d down -52% and 1h fc_short still negative.
18	PRSO	AVOID	4.0	Roth $25M ATM agreement is direct dilution overhang despite +65-193% forecasts.
19	AKTX	WAIT	3.9	Maxim $30 PT bullish but 1wk forecast -100% signals model breakdown; 1h dd -42.74%.
20	NXTC	AVOID	3.8	Avere merger + $320M PIPE = structural change, shortFloat 49.58%, near-term bullish only 0.2.
21	IPWR	WAIT	3.7	NVIDIA Rubin LOI intriguing but $75M shelf filed 7/10 = dilution ready; PS 2030 absurd.
22	COCP	WAIT	3.5	Near-term bullish 1.0 but PS 52, profit margin -3924%, all TF drawdowns -15-42%.
23	RGNT	WAIT	3.4	Japan patent + EU approval positive but bullish_prob null and only 2 TFs available.
24	CNCK	WAIT	3.3	Bhutan bitcoin treasury mandate is a catalyst but 1h fc_short -5.99% and fwdPe 1362.
25	INTZ	AVOID	3.1	1h forecasts turn negative, back-to-back Zacks 'sinks as market gains' — momentum broken.
26	LUCY	AVOID	2.9	Claude AI integration cool but warrant exercise = dilution and 1wk fc_long -83.86%.
27	WW	AVOID	2.7	Only 1d TF available, shortFloat 20.69%, debtEq 1.76, salesYoY -9.61% — broken business.
28	USBC	AVOID	2.4	1d fc_short -52.78% contradicts 1h/4h bullishness; near-term bullish 0.0; -87% year.
29	CRE	AVOID	2.2	1h fc_short -4.89%, -95.93% year, targetUpsidePct null — no visibility.
30	QCLS	AVOID	1.8	Terminated Lightsolver license 6/26 is a materially negative catalyst; bullish_prob 0.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord